LEE, Changsik,LEE, Jaekwang,SONG, Hyeseung,BAE, Daekwon,HA, Nina,KIM, Il Hyang,BAE, Daekwon,裵大權,HA, Nina,河妮娜,KIM, Il Hyang,金一香
申请号：
HK18110911
公开号：
HK1251556A1
申请日:
2018.08.23
申请国别(地区):
HK
年份:
2019
代理人:
摘要：
The present invention relates to novel heterocyclicalkyl derivatives having histone deacetylase (HDAC) inhibitory activity, optical isomers thereof or pharmaceutically acceptable salts thereof, the use thereof for the preparation of medicaments, pharmaceutical compositions containing the same, a method for treating diseases using the composition, and methods for preparing the novel heterocyclicalkyl derivatives. The novel heterocyclicalkyl derivatives according to the present invention are selective histone deacetylase (HDAC) inhibitors, and may be effectively used for the treatment of histone deacetylase-mediated diseases, such as cell proliferative diseases, inflammatory diseases, autosomal dominant diseases, genetic metabolic diseases, autoimmune diseases, acute/chronic neurological disease, hypertrophy, heart failure, ocular diseases, or neurodegenerative diseases.
